Bursitis Treatment Market - Industry Trends andt
Bursitis Treatment Market - Industry Trends and Forecast to 2026 with
key market like Vesalius Medical Technologies, Endo Pharmaceuticals Inc, Teva
Pharmaceutical Industries Ltd, Pfizer Inc, Mylan N.V., Hikma Pharmaceuticals
PLC.
Bursitis
Treatment Market By Type (Anterior Achilles Tendon Bursitis, Posterior
Achilles Tendon Bursitis, Hip Bursitis and Others), Treatment Type (Medication,
Surgery, Physical Therapy), Drugs (Corticosteroids, Antibiotics, Nonsteroidal
Anti-Inflammatory Drugs and Others), End- Users (Hospitals, Homecare, Specialty
Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies,
Online Pharmacies, Drug Stores), Geography (North America, South America, Europe,
Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global
Bursitis Treatment Market
Global bursitis
treatment market is rising gradually with a steady CAGR in the forecast period
of 2021-2026. The report contains data of the base year 2018 and historic year
2017. Growing demand of disease specific treatment for bursitis and prevalent
cases of family history of this condition are the key drivers for market
growth.
Download Full Sample Report Of Bursitis
Treatment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bursitis-treatment-market
Market Definition:
Global Bursitis Treatment Market
Bursitis is severe
inflammation of a bursa. It causes tenderness, swelling and pain in the joints.
Bursae is small jelly like sacs that are located throughout the body
predominantly in around the shoulder, elbow, hip, knee, and heel is act as
cushions to help reduce the friction. The patients with bursitis experienced
dull pain, tenderness, and stiffness near the affected bursa.
Market Drivers
Vulnerable aging population can enhance the market growth
Rise in prevalence of arthritis and sudden injuries can develop
bursitis can also act as a market driver
Accelerates demand of novel therapies is driving the growth of
this market
Adoption of unhealthy lifestyles and vigorous aggressive
exercise which involved overuse and repeated movements of body can cause
bursitis is enhancing the market growth
Market Restraints
Effective treatment is unavailable and unaffordable which can
hamper the market growth
Preference over non-conventional therapy over pharmacological
therapies is restraint the market growth
Lack of skilled expertise in some middle-income and low-income
countries also acting as a challenging factor for the growth of this market
Segmentation: Global
Bursitis Treatment Market
By Type
·
Anterior
Achilles Tendon Bursitis
·
Posterior
Achilles Tendon Bursitis
·
Hip
Bursitis
·
Others
By Treatment Type
·
Medication
·
Surgery
·
Physical
Therapy
By Drugs
·
Corticosteroids
·
Dexamethasone
·
Prednisone
·
Antibiotic
·
Flucloxacillin
·
Erythromycin
·
Clarithromycin
·
Nonsteroidal
Anti-Inflammatory Drugs
·
Others
By End Users
·
Hospitals
·
Homecare
·
Specialty
Clinics
·
Others
By Distribution Channel
·
Hospital
Pharmacies
·
Retail
Pharmacies
·
Online
Pharmacies
·
Drug
Stores
By Geography
·
North
America
·
U.S.
·
Canada
·
Mexico
·
South
America
·
Brazil
·
Rest
of South America
·
Europe
·
Germany
·
France
·
United
Kingdom
·
Italy
·
Spain
·
Russia
·
Turkey
·
Belgium
·
Netherlands
·
Switzerland
·
Rest
of Europe
·
Asia-Pacific
·
Japan
·
China
·
South
Korea
·
India
·
Australia
·
Singapore
·
Thailand
·
Malaysia
·
Indonesia
·
Philippines
·
Rest
of Asia Pacific
·
Middle
East & Africa
·
South
Africa
·
Rest
of Middle East & Africa
Key Developments in the Market:
In September 2017,
Vesalius Medical Technologies received the U.S. patent for its Bursitis
treatment device and method for the treatment of inflammation of a bursa in a
patient's joint. It was filed in the September 2015. The U.S. grants of this
patents enables the company to generates the revenue by out-licensed their
products to other pharma companies.
Competitive Analysis:
Global
bursitis treatment market is highly fragmented and the major players have
used various strategies such as new product launches, expansions, agreements,
joint ventures, partnerships, acquisitions, and others to increase their
footprints in this market. The report includes market shares of global bursitis
treatment market for Global, Europe, North America, Asia-Pacific, South America
and Middle East & Africa.
Key Market Players:
Few of the major
competitors currently working in the global bursitis treatment market are Bone
Therapeutics SA, Vesalius Medical Technologies, Endo Pharmaceuticals Inc, Teva
Pharmaceutical Industries Ltd, Pfizer Inc, Mylan N.V., Hikma Pharmaceuticals
PLC, Vintage Labs, Jubilant Life Sciences Ltd, Sun Pharmaceutical Industries
Limited, Larken Laboratories, Inc, Lannett, WOCKHARDT, Fera Pharmaceuticals and
others
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-bursitis-treatment-market
Reasons
for Buying this Report
This
report provides pin-point analysis for changing competitive dynamics
It
provides a forward looking perspective on different factors driving or
restraining market growth
It
provides a six-year forecast assessed on the basis of how the market is predicted
to grow
It helps
in understanding the key product segments and their future
It
provides pin point analysis of changing competition dynamics and keeps you
ahead of competitors
It helps
in making informed business decisions by having complete insights of market and
by making in-depth analysis of market segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-bursitis-treatment-market
About
Us:
Data
Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient
information for your business to thrive in the market
Contact:
Tel:
+1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse
Related Reports @
Easy Peel Film Packaging Market